Evaluation of 24 hour glycemic control in T2DM patients receiving the novel formulation of U-200 human pre-mix insulin

Rao Sameer

0 views
0 downloads

Powered byMorressier logo black

Discover more research and events on morressier.com

ImprintTerms of ServicePrivacy PolicyAccessibility